Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanchang UniversityNo recent work listed

Lu Fang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4159-4517; OpenAlex author ID A5090771612. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper

Papers 2

  1. FBXO22 Accelerates Pancreatic Cancer Growth by Deactivation of the Hippo Pathway via Destabilizing LATS2. Last author DOI 10.1007/s10620-022-07780-6↗
  2. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1. Co-author DOI 10.1186/s12967-021-03007-w↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jingsheng Ma · 1 shared paper, 2023 · strength 0.20
  2. Wentao Yang · 1 shared paper, 2023 · strength 0.20
  3. Lin Zhong · 1 shared paper, 2023 · strength 0.20
  4. Yeqing Zou · 1 shared paper, 2021 · strength 0.14
  5. Xiaowei Fu · 1 shared paper, 2021 · strength 0.14
  6. Xueqiang Deng · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.